TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
ORIC

Oric Pharmaceuticals Inc

Healthcare · Biotechnology

12.50$ +2.3% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow ORIC
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – –
– +0.3% +13.8% -5.6% -7.5% +7.7% +6.8% +7.3% +10.2%
– +216,029.0% +133.3% +382.4% +143.5% +12.5% +5.3% +32.8% +23.9%
– +92.8% +127.7% +2,206.7% -49.4% +12.8% – – –
– -844.2% – +67.6% +99.2% -110.9% – -59.8% -377.4%
– +8.0% +46.3% -13.2% +40.8% +121.3% -59.1% +39.9% -40.1%
– +74.0% +51.2% +28,019.7% – -169.0% -60.3% – -768.7%
– – +86.6% +283.2% -81.2% -98.9% – – –
– +14,518.5% +86.3% +253.7% -80.4% -48.7% +239.6% +47.7% +95.7%
– – +176.6% -123.0% – -207.5% – – -138.1%
– – – – – – – – –

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?